机译:土耳其成人哮喘患者血浆纤溶酶原激活物抑制剂1型基因4G / 5G多态性
Departments of Medical Biology and Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey Eskisehir Osmangazi UEniversitesi Tip Fakueltesi Tibbi Biyoloji AD 26480 Eskisehir Turkey;
Departments of Chest Diseases, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey;
Departments of Medical Biology and Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey;
Departments of Medical Biology and Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey;
Department of Biology, Faculty of Science and Art, Mus Alparslan University, Mus, Turkey;
Departments of Chest Diseases, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey;
Department of Molecular Biology and Genetic, Faculty of Science and Letters, Adiyaman University, Adiyaman, Turkey;
Departments of Medical Biology and Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey;
Department of Biostatistics, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey;
机译:纤溶酶原激活物抑制剂1型基因4G / 5G多态性与土耳其人群中的高血压患者有关。
机译:急性脑卒中患者血浆纤溶酶原激活物抑制剂1型(PAI-1)基因4G / 5G多态性频率与血浆PAI-1酶活性之间的相关性研究
机译:急性脑卒中患者血浆纤溶酶原激活物抑制剂1型(PAI-1)基因4G / 5G多态性频率与血浆PAI-1酶活性之间的相关性研究
机译:冠状动脉疾病患者的纤溶酶原激活剂抑制剂I(PAI-I)-675 5G / 4G多态性
机译:魁北克家庭研究中PAI-1 4G / 5G多态性与血压的关联:与肥胖,身体活动和ACE I / D多态性的相互作用。
机译:纤溶酶原激活物抑制剂-1基因中的−675 4G / 5G多态性与哮喘风险相关:一项荟萃分析
机译:纤溶酶原激活物抑制物1基因的(-675G / A)4G / 5G多态性在土耳其人群缺血性卒中心房颤动中的作用